0001140361-24-017566.txt : 20240403
0001140361-24-017566.hdr.sgml : 20240403
20240403160148
ACCESSION NUMBER: 0001140361-24-017566
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240401
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: USMAN NASSIM
CENTRAL INDEX KEY: 0001206872
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 24818599
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GYRE THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 562020050
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (619) 949-3681
MAIL ADDRESS:
STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20150820
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
4
1
form4.xml
FORM 4
X0508
4
2024-04-01
0001124105
GYRE THERAPEUTICS, INC.
GYRE
0001206872
USMAN NASSIM
C/O GYRE THERAPEUTICS, INC.
12770 HIGH BLUFF DRIVE, SUITE 150
SAN DIEGO
CA
92130
true
true
Common Stock
2024-04-01
4
M
0
20000
6.93
A
21636
D
Common Stock
2024-04-01
4
S
0
20000
16.15
D
1636
D
Common Stock
563
I
By The Usman Family Trust
Common Stock
77
I
By Nassim Usman IRA
Stock Option (Right to Buy)
6.93
2024-04-01
4
M
0
20000
0
D
2033-10-31
Common Stock
20000
301652
D
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $15.80 to $17.15. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
This option is vested in full.
/s/ Ruoyu Chen, as attorney-in-fact for Nassim Usman
2024-04-03